RaQualia Pharma
4579.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| HK inno.N Corporationjoint holder | 15.94% |
| YUICHI KAKINUMA | 9.17% |
| Heights Capital Management, Inc. | 5.41% |
Each holder's own ratio from its most recent large-shareholding report.
Ownership history · 13
| Holder | Ratio | Change |
|---|---|---|
| YUICHI KAKINUMA2026-01-29 | 9.17% | no change |
| HK inno.N Corporation2026-01-29joint | 15.94% | no change |
| Yuichi Kakinuma2026-01-29joint | 9.17% | -0.58pp |
| HK inno.N Corporation2026-01-29 | 15.94% | +5.34pp |
| Yuichi Kakinuma2025-12-12joint | 9.75% | no change |
| HK inno.N Corporation2025-12-12 | 10.60% | no change |
| YUICHI KAKINUMA2025-12-12 | 9.75% | -0.01pp |
| HK inno.N Corporation2025-12-12joint | 10.60% | -0.01pp |
| KAKINUMA YUICHI2025-04-18 · amended | 9.76% | no change |
| HK inno.N Corporation2025-04-18 · amendedjoint | 10.61% | no change |
| Yuichi Kakinuma2025-04-18joint | 9.76% | new |
| HK inno.N Corporation2025-04-18 | 10.61% | new |
| Heights Capital Management, Inc.2025-03-31 · amended | 5.41% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.